For instance, some researchers have shown that transient receptor potential channel 5 (TrpC-5)-containing EVs in breast cancer and P-glycoprotein (P-gp)-containing microvesicles in ovarian cancer are responsible for chemotherapeutic resistance [59,60]. Here, TRPC5 is linked to ovarian carcinoma.